These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7255223)

  • 1. [Effect of probucol on blood lipid level and lecithin acyltransferase activity in type II hyperlipoproteinemia].
    Sznajderman M; Kuczyńska K
    Pol Arch Med Wewn; 1981 Mar; 65(3):219-25. PubMed ID: 7255223
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol].
    Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z
    Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586
    [No Abstract]   [Full Text] [Related]  

  • 3. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
    Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
    Artery; 1993; 20(1):1-18. PubMed ID: 8447724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Probucol : comparison of its effect with that of a placebo in hyperlipoproteinemia type II].
    Beaumont V
    Nouv Presse Med; 1980 Oct; 9(40):3011-3. PubMed ID: 7443442
    [No Abstract]   [Full Text] [Related]  

  • 5. [Further studies on the activity of fatty acid lecithin acyltransferase in patients with type II and IV hyperlipoproteinemia].
    Kuczyńska K; Sznajderman M
    Pol Arch Med Wewn; 1980 Oct; 64(4):335-40. PubMed ID: 7454597
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
    Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of probucol on lipid and lipoprotein levels and serum apolipoproteins A1 and B in patients with hyperlipoproteinemia type II].
    Sznajderman M; Zawadzki Z
    Kardiol Pol; 1985; 28(10):628-36. PubMed ID: 3938501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of probucol on serum cholesterol concentration in primary hyperlipoproteinemia].
    Kawecka-Jaszcz K; Kocemba J; Wasowicz B; Król W
    Kardiol Pol; 1982; 25(5-6):377-82. PubMed ID: 6759746
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Atherosclerosis; 1980 Nov; 37(3):469-74. PubMed ID: 7458992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pravastatin on lipid transfer protein and lecithin cholesterol acyltransferase in heterozygous familial hypercholesterolemia.
    Fusegawa Y; Tada H; Oguma T; Shiina Y; Moriguchi EH; Tanabe T; Tamachi H; Tomoda H; Goto Y
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):81-6. PubMed ID: 7701533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin:cholesterol acyltransferase activity in relation to lipoprotein concentration and lipid composition.
    Leiss O; Murawski U; Egge H
    Scand J Clin Lab Invest Suppl; 1978; 150():77-84. PubMed ID: 218279
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of probucol of bile composition].
    Marecek Z; Jirsa M; Kordac V; Kucerová K
    Vnitr Lek; 1981 Jul; 27(7):667-70. PubMed ID: 7303501
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.
    Mellies MJ; Gartside PS; Glatfelter L; Vink P; Guy G; Schonfeld G; Glueck CJ
    Metabolism; 1980 Oct; 29(10):956-64. PubMed ID: 6999291
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of probucol on homozygous cases of familial hypercholesterolemia.
    Yamamoto A; Matsuzawa Y; Kishino B; Hayashi R; Hirobe K; Kikkawa T
    Atherosclerosis; 1983 Aug; 48(2):157-66. PubMed ID: 6615580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with probucol of children with familial hypercholesterolaemia.
    Sanjurjo P; Martul P; Sasieta M; Lafuente P; Ariza F; Cabeza I
    Acta Paediatr Scand; 1988 Jan; 77(1):132-5. PubMed ID: 3285634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterol synthesis in vitro in freshly isolated blood mononuclear leukocytes from familial hypercholesterolemic patients treated with probucol.
    McNamara DJ; Bloch CA; Botha A; Mendelsohn D
    Biochim Biophys Acta; 1985 Mar; 833(3):412-6. PubMed ID: 3970963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probucol on the composition and in vitro catabolism of LDL in type IIa hypercholesterolemia.
    Baudet MF; Esteva O; Dachet C; Jacotot B
    Atherosclerosis; 1986 Oct; 62(1):65-71. PubMed ID: 3778575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of homozygous familial hypercholesterolaemia with probucol.
    Baker SG; Joffe BI; Mendelsohn D; Seftel HC
    S Afr Med J; 1982 Jul; 62(1):7-11. PubMed ID: 7089781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet function in familial hypercholesterolaemia in South Africa and the effects of probucol.
    Bradlow BA; Chetty N; Birnbaum M; Baker SG; Seftel HC
    Thromb Res; 1982 Apr; 26(2):91-9. PubMed ID: 6214040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.